CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Current Assets:
Cash and cash equivalents	$ 167,826	$ 255,303
Restricted cash	131,321	215,325
Accounts receivable, less allowance for doubtful accounts of $4,047 and $3,587 at December 31, 2014 and June 30, 2015, respectively	407,984	353,713
Short-term investments (restricted investments of $132,808 and $209,537 at December 31, 2014 and June 30, 2015, respectively)	312,306	224,361
Deferred income taxes	26,476	27,226
Pharmaceutical inventory	42,294	39,375
Other current assets (restricted deposits of $30,620 and $27,030 at December 31, 2014 and June 30, 2015, respectively)	81,634	52,246
Total Current Assets	1,169,841	1,167,549
Property and equipment, net	177,366	171,916
Restricted long-term investments	29,731	43,293
Other long-term assets	13,632	11,575
Goodwill	623,827	566,106
Other intangible assets, net	149,113	133,718
Total Assets	2,163,510	2,094,157
Current Liabilities:
Accounts payable	58,003	63,929
Accrued liabilities	159,132	154,931
Medical claims payable	255,524	278,482
Other medical liabilities	141,221	72,719
Current maturities of long-term debt and capital lease obligations	15,959	15,779
Total Current Liabilities	629,839	585,840
Long-term debt and capital lease obligations	249,264	255,742
Deferred income taxes	27,250	30,950
Tax contingencies	11,368	12,320
Contingent consideration	63,542	49,839
Deferred credits and other long-term liabilities	19,574	19,951
Total Liabilities	1,000,837	954,642
Redeemable Non-controlling interest	$ 8,198	$ 5,957
STOCKHOLDERS' EQUITY
Preferred stock, par value $.01 per share Authorized-10,000 shares at December 31, 2014 and June 30, 2015 - Issued and outstanding-none
Other Stockholders' Equity:
Additional paid-in capital	$ 1,095,772	$ 1,018,266
Retained earnings	1,191,828	1,179,897
Accumulated other comprehensive loss	(167)	(143)
Ordinary common stock in treasury, at cost, 23,150 shares and 24,212 shares at December 31, 2014 and June 30, 2015, respectively	(1,133,470)	(1,064,963)
Total Stockholders' Equity	1,154,475	1,133,558
Total Liabilities, Redeemable Non-Controlling Interest and Stockholders' Equity	2,163,510	2,094,157
Ordinary common stock
STOCKHOLDERS' EQUITY
Common stock	$ 512	$ 501
Multi-Vote common stock
STOCKHOLDERS' EQUITY
Common stock